Apolipoprotein E (APOE) variants have been established as a strong risk factor for cardiovascular disease and Alzheimer’s disease (Bennet et al., 2007; Corder et al., 1994) and are associated with altered LDL-C levels. Here, APOE is linked to cardiovascular disorder.